COCP
Cocrystal Pharma, Inc.OTCQB
1d
5d
1m
6m
1y
5y
10y
Advanced Chart
  • Nov. 25, 2014, 12:59 PM
    • The merger between Cocrystal Pharma (OTCQB:COCP +10.9%) and RFS Pharma, LLC has closed. The shareholders of each company will each own ~50% of combined entity.
    • The merged organization will have a broad pipeline of products in hepatitis, influenza, rhinovirus, dengue fever and norovirus.
    • Dr. Gary Wilcox will be CEO and Co-Chairman of the new firm. RFS Founder and Chairman Dr. Raymond F. Schinazi will be the other Co-Chairman.
    | Nov. 25, 2014, 12:59 PM